Pharmacovigilance Market, By Type of Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified AD

Pharmacovigilance Market, By Type of Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring), By Type of Service Providers (In-House, Contract Outsourcing), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the Global Pharmacovigilance market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Pharmacovigilance market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation. Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, and Johnson and Johnson
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pharmacovigilance market
Detailed Segmentation:
Global Pharmacovigilance Market, By Type of Clinical Trial Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Global Pharmacovigilance Market, By Type of Method:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Global Pharmacovigilance Market, By Type of Service Providers:
In-House
Contract Outsourcing
Global Pharmacovigilance Market, By Region:
North America
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
U.S.
Canada
Latin America
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Clinical Trail Phases:
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Type of Method
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Type of Service Providers
In-House
Contract Outsourcing
By Country
North Africa
Central Africa
South Africa
Company Profiles
Accenture Plc *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bristol-Myers Squibb
Clinquest Group B.V.
Cognizant Technology Solutions
Covance, Inc.
GlaxoSmithKline
ICON, Plc
iGATE Corporation
Arriello
iMEDGlobal Corporation
Diamond Pharma Services
Infosys
Ergomed plc
inVentiv Health Inc.
APCER Life Sciences
ArisGlobal
Johnson and Johnson
“*” marked represents similar segmentation in other categories in the respective section.